Follow
Max Kuhn
Max Kuhn
Posit PBC (formerly RStudio)
Verified email at posit.co
Title
Cited by
Cited by
Year
Welcome to the Tidyverse
H Wickham, M Averick, J Bryan, W Chang, LDA McGowan, R François, ...
Journal of open source software 4 (43), 1686, 2019
119612019
Building predictive models in R using the caret package
M Kuhn
Journal of Statistical Software 28 (5), 1-26, 2008
78462008
Applied predictive modeling
M Kuhn, K Johnson
Springer, 2013
75912013
Feature engineering and selection: A practical approach for predictive models
M Kuhn, K Johnson
Chapman and Hall/CRC, 2019
7692019
Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis
R Craig-Schapiro, M Kuhn, C Xiong, EH Pickering, J Liu, TP Misko, ...
PloS one 6 (4), e18850, 2011
2622011
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease
WT Hu, DM Holtzman, AM Fagan, LM Shaw, R Perrin, SE Arnold, ...
Neurology 79 (9), 897-905, 2012
2612012
Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease
HD Soares, WZ Potter, E Pickering, M Kuhn, FW Immermann, DM Shera, ...
Archives of neurology 69 (10), 1310-1317, 2012
226*2012
Novel CSF biomarkers for Alzheimer’s disease and mild cognitive impairment
WT Hu, A Chen-Plotkin, SE Arnold, M Grossman, CM Clark, LM Shaw, ...
Acta neuropathologica 119, 669-678, 2010
1972010
Chronic suppression of phosphodiesterase 10A alters striatal expression of genes responsible for neurotransmitter synthesis, neurotransmission, and signaling pathways …
RJ Kleiman, LH Kimmel, SE Bove, TA Lanz, JF Harms, A Romegialli, ...
Journal of Pharmacology and Experimental Therapeutics 336 (1), 64, 2011
1082011
Polyomic profiling reveals significant hepatic metabolic alterations in glucagon-receptor (GCGR) knockout mice: implications on anti-glucagon therapies for diabetes
J Yang, ML MacDougall, MT McDowell, L Xi, R Wei, WJ Zavadoski, ...
BMC genomics 12, 1-14, 2011
932011
Accurate and fast feature selection workflow for high-dimensional omics data
Y Perez-Riverol, M Kuhn, JA Vizcaíno, MP Hitz, E Audain
PloS one 12 (12), e0189875, 2017
802017
Postnatal PPARδ activation and myostatin inhibition exert distinct yet complimentary effects on the metabolic profile of obese insulin-resistant mice
BL Bernardo, TS Wachtmann, PG Cosgrove, M Kuhn, AC Opsahl, ...
PLoS one 5 (6), e11307, 2010
792010
Immuno-amplification
J Nadeau, T Hellyer, D Berger, W Nussbaumer, R Rosenstein, A Kuhn, ...
US Patent 7,932,060, 2011
742011
Tidy modeling with R
M Kuhn, J Silge
" O'Reilly Media, Inc.", 2022
712022
Quantitative assessment of the impact of fluorine substitution on P-glycoprotein (P-gp) mediated efflux, permeability, lipophilicity, and metabolic stability
M Pettersson, X Hou, M Kuhn, TT Wager, GW Kauffman, PR Verhoest
Journal of medicinal chemistry 59 (11), 5284-5296, 2016
632016
Homogeneous real-time detection of single-nucleotide polymorphisms by strand displacement amplification on the BD ProbeTec ET system
SS Wang, K Thornton, AM Kuhn, JG Nadeau, TJ Hellyer
Clinical chemistry 49 (10), 1599, 2003
562003
Ultra-sensitive measurement of IL-17A and IL-17F in psoriasis patient serum and skin
C Soderstrom, G Berstein, W Zhang, H Valdez, L Fitz, M Kuhn, S Fraser
The AAPS journal 19 (4), 1218-1222, 2017
532017
Improving the odds of success in drug discovery: choosing the best compounds for in vivo toxicology studies
TT Wager, BL Kormos, JT Brady, Y Will, MD Aleo, DB Stedman, M Kuhn, ...
Journal of Medicinal Chemistry 56 (23), 9771-9779, 2013
512013
Futility analysis in the cross-validation of machine learning models
M Kuhn
arXiv preprint arXiv:1405.6974, 2014
502014
Leveraging of rifampicin-dosed cynomolgus monkeys to identify bile acid 3-O-sulfate conjugates as potential novel biomarkers for organic anion-transporting polypeptides
R Thakare, H Gao, RE Kosa, YA Bi, MVS Varma, MA Cerny, R Sharma, ...
Drug Metabolism and Disposition 45 (7), 721-733, 2017
412017
The system can't perform the operation now. Try again later.
Articles 1–20